John Cannon Named Acting CFO of ConvaTec
LUXEMBOURG, July 1, 2013
LUXEMBOURG, July 1,2013 /PRNewswire/ --ConvaTec, a privately-held developer
and marketer of innovative medical technologies, today announced that John
Cannon has been named acting Chief Financial Officer of the company.
Mr. Cannon succeeds Edward Borkowski, who has left the company.
"I would like to thank Ed for his contributions to ConvaTec's success over the
past year and wish him well in the future," said Ken Berger, CEO of ConvaTec.
Mr. Cannon is currently Vice President, Finance, for ConvaTec's global
Operations, which includes manufacturing, and for its Asia-Pacific and EMEA
Mr. Cannon previously was with PMC Treasury, a financial advisory firm for
private-equity sponsored companies, and was the senior financial officer with
Singer Sewing. Earlier, he spent fifteen years in banking with Bankers
Trust/Deutsche Bank, including eight years in Asia-Pacific. He has a BS
degree in physics and economics from Haverford College and an MBA from New
York University's Stern School of Business.
ConvaTec is a leading developer and marketer of innovative medical
technologies that have helped improve the lives of millions of people
worldwide. With four key focus areas – Ostomy Care, Wound Therapeutics,
Continence and Critical Care, and Infusion Devices – ConvaTec products support
healthcare professionals from the hospital to the community health setting.
The company is owned by Nordic Capital and Avista Capital Partners. For more
information, please visit www.convatec.com
Contact: Investor Relations: Tim Winston, VP, Treasurer, ConvaTec,
908-904-2988, email@example.com; Media Relations: Punnie Donohue,
ConvaTec, 908-904-2151, firstname.lastname@example.org
Press spacebar to pause and continue. Press esc to stop.